Top Markets
#1 Black Phoenix Black Phoenix +342.75%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +61.75%
#4 Gold Park Gold Park +55.15%
#5 BasedHype BasedHype +29.66%
#6 Acurast Acurast +25.65%
#7 Cryptopia Cryptopia +22.04%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.03%
#9 Avantis Avantis +18.81%
#10 MYX Finance MYX Finance +14.22%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Clasificación en acciones #41092
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Precio por acción
$0.0202
Última sincronización: 2024-11-19
Capitalización bursátil
$44.67K
Cambio (1 día)
-0.49%
Cambio (1 año)
0.00%
País
IL
Comercio Notable Labs, Ltd. (NTBL)

Categoría

Healthcare
Ingresos de Notable Labs, Ltd. (NTBL)
Ingresos en Jun 2024 TTM: $3.00K
Según los últimos informes financieros de Notable Labs, Ltd., los ingresos actuales de la empresa (TTM) son $3.00K. En 2022, la empresa obtuvo unos ingresos de $8.00K una disminución en comparación con los ingresos del año 2021, que fueron de $285.00K. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Notable Labs, Ltd. desde 2015 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
2026 (TTM) $3.00K -99.03%
2023 $310.00K 3,775.00%
2022 $8.00K -97.19%
2021 $285.00K -69.09%
2020 $922.00K 64.06%
2019 $562.00K -3.93%
2018 $585.00K -95.78%
2017 $13.86M 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 420,809,900.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 200,709,476.97%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 337,026,123.20%
BE